Agenus
AGEN
#8939
Rank
โ‚ฌ0.11 B
Marketcap
3,48ย โ‚ฌ
Share price
-2.64%
Change (1 day)
6.78%
Change (1 year)

Revenue for Agenus (AGEN)

Revenue in 2025 (TTM): โ‚ฌ95.59 Million

According to Agenus 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ91.65 Million. In 2024 the company made a revenue of โ‚ฌ99.42 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ0.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agenus from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ95.59 M-3.85%
2024 โ‚ฌ99.42 M-29.69%
2023 โ‚ฌ0.14 B54.73%
2022 โ‚ฌ91.38 M-65%
2021 โ‚ฌ0.26 B264.2%
2020 โ‚ฌ71.68 M-46.48%
2019 โ‚ฌ0.13 B316.57%
2018 โ‚ฌ32.15 M-10.02%
2017 โ‚ฌ35.73 M66.52%
2016 โ‚ฌ21.46 M-5.45%
2015 โ‚ฌ22.69 M295.62%
2014 โ‚ฌ5.73 M160.18%
2013 โ‚ฌ2.2 M-81.73%
2012 โ‚ฌ12.06 M468.61%
2011 โ‚ฌ2.12 M-15.99%
2010 โ‚ฌ2.52 M8.53%
2009 โ‚ฌ2.32 M22.73%
2008 โ‚ฌ1.89 M-50.13%
2007 โ‚ฌ3.8 M624.95%
2006 โ‚ฌ0.52 M-1.37%
2005 โ‚ฌ0.53 M2.03%
2004 โ‚ฌ0.52 M-81.4%
2003 โ‚ฌ2.8 M-14.14%
2002 โ‚ฌ3.26 M-36.73%
2001 โ‚ฌ5.15 M997.72%
2000 โ‚ฌ0.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
โ‚ฌ55.11 B 60,028.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.33 B 39,545.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ79.06 B 86,158.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ2.23 M-97.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.21 B 44,863.45%๐Ÿ‡บ๐Ÿ‡ธ USA